Laurus Labs launches Pregabalin Capsules in US marketplace

Laurus Labs launches Pregabalin Capsules in US marketplace

by admin- Monday, July 22nd, 2019 04:00:30 PM

Laurus Labs has introduced the launch of the everyday model of Lyrica, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, a hundred mg, a hundred and fifty mg, 2 hundred mg, 225 mg, & 300 mg) in US market at the side of its exclusive distribution companion Rising Pharmaceuticals, a Rising Pharma Holdings Inc. Agency.

Rising these days acquired the very last approval from the USA Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA).

News Updates